Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals

Pharmacological Research

Volumn 52, Issue 2, 2005, Pages 162-166

  Gumieniczek, Anna ^a   Hopkała, Hanna ^a   Roliński, Jacek ^a   Bojarska Junak, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Alloxan diabetic animals; Interleukin 6; Oxidative stress; Plasma; Repaglinide

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CARBONYL DERIVATIVE; INTERLEUKIN 6; REPAGLINIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; EX VIVO STUDY; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN METHYLATION; RABBIT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; CARBAMATES; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; INSULIN; PIPERIDINES; RABBITS;

EID: 20444503262     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.02.019     Document Type: Article

References (28)

1. K. Esposito, F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, and M. Ciotola Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Role of oxidative stress Circulation 106 2002 2067 2072
2. J.C. Pickup, G. Chusney, S.M. Thomas, and D. Burt Plasma interleukin-6, tumor necrosis factor α and blood cytokine production in type 2 diabetes Life Sci 67 2000 291 300
3. S. Kado, T. Nagase, and N. Nagata Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus Acta Diabetol 36 1999 67 72
4. A.M. Schmidt, S.D. Yan, J.L. Wautier, and D. Stern Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circ Res 84 1999 489 497
5. E. Ho, and T.M. Bray Antioxidants, NFκB activation and diabetogenesis Proc Soc Exp Biol Med 222 1999 205 213
6. H. Ghanim, R. Garg, A. Aljada, P. Mohanty, Y. Kumbkarni, and E. Assian Suppression of nuclear factor-κB and stimulation of inhibitor κB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese J Clin Endocrinol Metab 86 2001 1306 1312
7. O.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
8. A. Kyaw A simple colorimetric method for ascorbic acid determination in blood plasma Clin Chim Acta 86 1978 153 157
9. N.J. Miller, C. Rice-Evans, M.J. Davies, V. Gopinathan, and A. Milner A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates Clin Sci 84 1993 407 412
10. R.L. Levine, D. Garland, C.N. Oliver, A. Amici, J. Climent, and A. Lenz Determination of carbonyl content in oxidatively modified proteins Meth Enzymol 186 1990 464 478
11. I. Akkuş, S. Kalak, H. Vural, O. Çaglayan, E. Menekşe, and G. Can Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus Clin Chim Acta 244 1996 221 227
12. J. Škrha, M. Prázný, J. Hilgertová, and H. Weiserová Serum α-tocopherol and ascorbic acid concentrations in type 1 and type 2 diabetic patients with and without angiopathy Clin Chim Acta 329 2003 103 108
13. R. Ananthan, C. Baskar, V. NarmathaBai, L. Pari, M. Latha, and K.M. Ramkumar Antidiabetic effect of Gymnema montanum leaves: effect on lipid peroxidation induced oxidative stress in experimental diabetes Pharmacol Res 48 2003 551 556
14. A. Telci, U. Cakatay, S. Salman, I. Satman, and A. Sivas Oxidative protein damage in early stage type 1 diabetic patients Diabetes Res Clin Pract 50 2000 213 223
15. T. Tankova, D. Koev, L. Dakovska, and G. Kirilov The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients Diabetes Res Clin Pract 59 2003 43 49
16. G. De Matia, O. Laurenti, and D. Fava Diabetic endothelial dysfunction. Effect of free radical scavenging in type 2 diabetic patients J Diabetes Complications 17 2003 30 35
17. F. Natella, M. Nardini, M. Di Felice, and C. Scaccini Benzoic and cinnamic acid derivatives as antioxidants: structure-activity relation J Agric Food Chem 47 1999 1453 1459
18. G. Garrote, J.M. Cruz, A. Moure, H. Domínguez, and J.C. Parajó Antioxidant activity of byproducts from the hydrolytic processing lignocellulosic materials Trends Food Sci Technol 15 2004 191 200
19. R.F. Haseloff, I.E. Blasig, H. Meffert, and B. Ebert Hydroxyl radical scavenging and antipsoriatic activity of benzoic acid derivatives Free Radic Biol Med 9 1990 111 115
20. C.J. Bailey Potential new treatments for type 2 diabetes Trends Pharmacol Sci 21 2000 259 265
21. R.C. O'Brien, M. Luo, N. Balazs, and J. Mercuri In vitro and in vivo antioxidant properties of gliclazide J Diabetes Complications 14 2000 201 206
22. P. Martín-Gallán, A. Carrascosa, M. Gussinye, and C. Domínguez Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications Free Radic Biol Med 34 2003 1563 1574
23. P. Odetti, S. Garibaldi, G. Noberasco, I. Aragno, S. Valentini, and N. Traverso Levels of carbonyl groups in plasma proteins of type 2 diabetes mellitus subjects Acta Diabetol 36 1999 179 183
24. S.D. Stosic-Grujicic, D.M. Miljkovic, I.D. Cvetkovic, D.D. Maksimovic-Ivanic, and V. Trajkovic Immunosuppressive and anti-inflammatory action of antioxidants in rat autoimmune diabetes J Autoimmun 22 2004 267 276
25. P. Pozzilli, N. Visalli, M.G. Cavallo, A. Signore, M.G. Baroni, and R. Buzzetti Vitamin E and nicotinamide have similar effects in maintaining residual β-cell function in recent onset insulin-dependent diabetes Eur J Endocrinol 137 1997 234 239
26. T. Yatagai, T. Nakamura, S. Nagasaka, I. Kusaka, S. Ishikawa, and A. Yoshitaka Decrease in serum C-reactive protein levels by troglitazone is associated with pretreatment insulin resistance, but independent of its effect on glycemia, in type 2 diabetic subjects Diabetes Res Clin Pract 63 2004 19 26
27. N.V. Chu, Kong APS, D.D. Kim, D. Armstrong, S. Baxi, and R. Deutsch Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes Diabetes Care 25 2004 542 549
28. A. Aljada, R. Garg, H. Ghanim, P. Mohanty, W. Hamouda, and E. Assian Nuclear factor-κB suppressive and inhibitor-κB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an anti-inflammatory action J Clin Endocrinol Metab 86 2001 3250 3256